| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 01/29/2004 | US20040019044 Heterocyclic aminoalkyl pyridine derivatives as psychopharmaceuticals |
| 01/29/2004 | US20040019040 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
| 01/29/2004 | US20040019034 Pyrrolotriazolopyrimidinone derivatives |
| 01/29/2004 | US20040018972 Autoimmune diseases; antiallergens; rheumatic diseases; antiinflammatory agents |
| 01/29/2004 | US20040018956 Aporphine esters and their use in therapy |
| 01/29/2004 | US20040018558 Method for identifying modulators of G protein coupled receptor signaling |
| 01/29/2004 | US20040018251 Petasite extract is recovered from plant of the genus Petasites; effective in treating gastrointestinal diseases, asthmas, pollinosis, dysmenorrhea, eczemas, migraines, psoriasis and high blood pressure |
| 01/29/2004 | DE10232113A1 Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel Vardenafil hydrochloride trihydrate containing medicines |
| 01/29/2004 | DE10229778A1 Neue Verwendung von Imidazotriazinonen New use of imidazotriazinones |
| 01/29/2004 | DE10229379A1 EG-VEGF Rezeptor Antagonisten EG-VEGF receptor antagonists |
| 01/29/2004 | CA2492922A1 Substituted thiophene carboxamide compounds for the treatment of inflammation |
| 01/29/2004 | CA2492665A1 Azaindole kinase inhibitors |
| 01/28/2004 | EP1384477A1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
| 01/28/2004 | EP1383927A2 New polynucleotides and polypeptides of the erythropoietin gene |
| 01/28/2004 | EP1383895A2 Polynucleotides and polypeptides of the ifnalpha-5 gene |
| 01/28/2004 | EP1383892A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/28/2004 | EP1383789A2 Proteins associated with cell growth, differentiation, and death |
| 01/28/2004 | EP1383774A2 Dihydroimidazo[4,5-e]indole and 7h-pyrrolo[3,2-f]quinoxaline derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 01/28/2004 | EP1383772A2 Nitrogen-based camptothecin derivatives |
| 01/28/2004 | EP1383768A1 Imidazo-pyrimidine derivatives as ligands for gaba receptors |
| 01/28/2004 | EP1383765A1 Chemical compounds |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383740A2 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors |
| 01/28/2004 | EP1383578A1 Single dose aromatase inhibitor for treating infertility |
| 01/28/2004 | EP1383522A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 01/28/2004 | EP1383521A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/28/2004 | EP1383520A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/28/2004 | EP1383515A1 Activation of natural killer cells by adenosine a3 receptor agonists |
| 01/28/2004 | EP1383513A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 01/28/2004 | EP1383512A1 Use of sucralfate for the treatment of cervical erosion |
| 01/28/2004 | EP1383502A2 Compounds and methods for the treatment of urogenital disorders |
| 01/28/2004 | EP1383501A2 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 01/28/2004 | EP1383495A1 Duloxetine for treatment of hot flashes |
| 01/28/2004 | EP1383486A2 Compositions containing cgmp pde inhibitors and local anestetic agents for nasal application |
| 01/28/2004 | EP1313706A4 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 01/28/2004 | EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 01/28/2004 | CN1471515A Compounds effective as beta-2-adrenoreceptor agonists as well as PDE-4-inhibitors |
| 01/28/2004 | CN1471508A Selective androgen receptor modulators and methods of use thereof |
| 01/28/2004 | CN1471395A Apomorphine derivatives and methods for their use |
| 01/28/2004 | CN1470273A Medicine for treating gynaopathy and its preparation use thereof |
| 01/28/2004 | CN1470267A Chinese medicine composition for treating barrenness and aciesis |
| 01/28/2004 | CN1470263A Medicine for treating barrenness |
| 01/28/2004 | CN1470257A Sherong (ginseng-pilose antler) medicinal composition for treating premature ejaculation and its medicinal use |
| 01/28/2004 | CN1470250A External-use disinfecting medicinal preparation for women |
| 01/28/2004 | CN1470244A Use of N-acetyl-D-aminoglucose in preparation of skin membrane mucosa microecologica balance regulator medicines |
| 01/28/2004 | CN1470239A Testosterone intradermic sustained preparation |
| 01/28/2004 | CN1136219C Pyrazolopyrimidinone derivatives for the treatment of impotence |
| 01/28/2004 | CN1136196C Crystalline forms of 3-(2,4-dichlorl benzyl)-2-methyl-N-(Pentylsulfonyc)-3H-benzimidzole-5-carboxamide |
| 01/28/2004 | CN1135994C Exterior-applied chinese medicine for treating gastroenteropathy, gynopathy, arthropath and sore ulcer |
| 01/28/2004 | CN1135988C Use of botulinum toxin in preparing pharmaceutical composition for treating prostatic disorders |
| 01/28/2004 | CN1135986C Vaginal minocycline suppository |
| 01/28/2004 | CN1135985C Minocycline vaginal solution agent |
| 01/28/2004 | CN1135978C Lubricating cream for copulation |
| 01/28/2004 | CN1135975C Vitamin E and esters therof for use in the topical treatment of mucosal pathologies |
| 01/28/2004 | CN1135969C Aqueous pharmaceutical composition comprising active ingredient which is highly insoluble in water |
| 01/27/2004 | US6683192 Substituted benzo(b)thien compounds useful for modulating proliferation or differentiation of a cell, agonizes hedgehog mediated signal trasnduction with an ed50 of 1mm or less |
| 01/27/2004 | US6683111 Such as 2-ethoxy-3-(4-(2-xanthen-9-ylidene-ethoxy)-phenyl)-propionic acid; for treating conditions associated with peroxisome proliferator-activated receptors; treatment of diabetes/obesity |
| 01/27/2004 | US6683103 Sulfonamides containing oxazole and substituted thiophene rings, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683087 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 01/27/2004 | US6683081 Triazolotriazinones and the use thereof |
| 01/27/2004 | US6683071 Initiation of oestrus |
| 01/27/2004 | US6683055 Guanidine or amidine termined peptides |
| 01/27/2004 | CA2292920C New spiroimidazolin derivatives, the process for preparing them and the pharmaceutical compositions that contain them |
| 01/22/2004 | WO2004007522A2 Hormone-based nitrogen monoxide donor compounds and use thereof in obstetrics and gynecology |
| 01/22/2004 | WO2004007487A1 Crystalline forms |
| 01/22/2004 | WO2004007486A1 Maleate salts |
| 01/22/2004 | WO2004007485A1 Besylate salts |
| 01/22/2004 | WO2004007484A1 Fumarate salts |
| 01/22/2004 | WO2004007481A2 Substituted amine derivatives and methods of use in the treatment of angiogenesis relates disorders |
| 01/22/2004 | WO2004007458A1 Substituted 2-alkylamine nicotinic amide derivatives and use there of |
| 01/22/2004 | WO2004007457A2 Substituted benzylamine derivatives and methods of use |
| 01/22/2004 | WO2004007454A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 01/22/2004 | WO2004007453A1 Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 01/22/2004 | WO2004006895A1 Lasofoxifene tablet and its coating |
| 01/22/2004 | WO2004006894A1 Medicaments containing vardenafil hydrochloride trihydrate |
| 01/22/2004 | WO2004006853A2 Treatment and prophylaxis with 4-1bb-binding agents |
| 01/22/2004 | WO2004006847A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 01/22/2004 | WO2004006662A1 DISEASE MODEL ANIMAL CARRYING FOREIGN PPARα GENE TRANSFERRED THEREINTO AND USE THEREOF |
| 01/22/2004 | WO2003097665A3 Mid 241 receptor, a novel g-protein coupled receptor |
| 01/22/2004 | WO2003080545A3 Substituted phenylacetic acids |
| 01/22/2004 | WO2003044058A3 Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis |
| 01/22/2004 | WO2003041732A3 Contraceptive vaccine compositions comprising a peptide or a plurality of peptides encoded by all or part of the exon 1 of a fsh receptor |
| 01/22/2004 | WO2003024395A8 Linked biaryl compounds |
| 01/22/2004 | WO2003024390A3 Hydroxyeicosenoic acid analogs |
| 01/22/2004 | WO2002078643A3 Immunomodulation and effect on cell processes relating to serotonin family receptors |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040014992 A dichlorobenzylcyanide or a dichlorophenylcyclohexyl acetic acid methyl ester; use as antagonist of serotonin receptor and dopamine, treating attention deficit hyperactivity disorder, Parkinson's disease, nervous system disorders |
| 01/22/2004 | US20040014969 Such as methyl-4'-(4-((8-(acetylamino)ethyl)-2-naphthyl)oxy) butoxy)-(1,1'-biphenyl)-4-carboxylate; for treating/ preventing melatoninergic disorders |
| 01/22/2004 | US20040014802 Aminoindazole derivatives and intermediates, preparation thereof, and pharmaceutical compositions thereof |
| 01/22/2004 | US20040014798 Skin disorders; hormone replacement therapy |
| 01/22/2004 | US20040014788 Novel uses of combined selective dopamine d2 receptor antagonists and 5-ht receptor agonists |
| 01/22/2004 | US20040014787 Hormone inhibitors; controlling fertility |
| 01/22/2004 | US20040014769 Central nervous system disorders; antidepressants; anxiolytic agents; eating disorders |
| 01/22/2004 | US20040014768 Psychological disorders; schizophrenia |
| 01/22/2004 | US20040014761 Treatment of female sexual dysfunction with phosphodiesterase inhibitors |
| 01/22/2004 | US20040014760 4- (2-butylamino) -2, 7-dimethyl-8- (2-methyl-6-methoxypyrid-3-YL) pyrazolo- [1,5-A] -1,3,5-triazine, its enantiomers and pharmaceutically acceptable salts as corticotropin releasing factor receptor ligands |
| 01/22/2004 | US20040014755 Rho-kinase inhibitors |
| 01/22/2004 | US20040014743 Mbreast and prostate anticancer agents; viricides; alopecia |
| 01/22/2004 | US20040014725 Adjust diffusion of oxygen; respiratory system disorders; cardiovascular disorders |